Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 80 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 8598312

    Inhibitors of antigen presentation by MHC class II molecules

    Provid Pharmaceuticals Inc. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  2. US 8598364

    Oligomer-protease inhibitor conjugates

    Nektar Therapeutics · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  3. US 8598210

    Prolyl hydroxylase inhibitors and methods of use

    Akebia Therapeutics, Inc. · Granted Dec 3, 2013 · Expires Nov 28, 2033

    granted
  4. US 8592577

    Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted
  5. US 8586536

    Neprilysin inhibitors

    Theravance, Inc. · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted
  6. US 8580844

    Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities

    Georgia Regents Research Institute, Inc. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  7. US 8580822

    Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

    REVIVA PHARMACEUTICALS, INC. · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  8. US 8580802

    Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  9. US 8580773

    Small-molecule inhibitors of the androgen receptor

    The Regents of the University of California · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  10. US 8580852

    2-oxamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudopeptides

    The Regents of the University of California · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted
  11. AU 2012249536

    Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases

    CELGENE CORP [CH] · Granted Nov 7, 2013 · Expires Nov 2, 2033

    granted
  12. US 8575208

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Nov 5, 2013 · Expires Oct 31, 2033

    granted
  13. US 8569337

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted
  14. US 8563576

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  15. US 8563512

    Neprilysin inhibitors

    Theravance, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  16. US 8563559

    Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  17. US 8562948

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted
  18. US 8557552

    Selective neuronal nitric oxide synthase inhibitors

    Northwestern University · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  19. US 8557818

    Compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  20. US 8557812

    Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  21. US 8557833

    Aminopyrimidines useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  22. US 8557800

    Sphingosine kinase inhibitors

    Apogee Biotechnology Corporation · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted
  23. US 8552067

    Macromolecular conjugates of cystic fibrosis transmembrane conductance regulator protein inhibitors and uses therefor

    The Regents of the University of California · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted
  24. US 8551997

    Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use

    The Board of Regents of the University of Texas System · Granted Oct 8, 2013 · Expires Oct 3, 2033

    granted